Improved Pharma announces new collaboration

Improved Pharma is pleased to announce the addition of Ruba Alajlouni to the team. Ruba brings expertise in regulatory and quality compliance along with hands-on experience in microbiology, cell culture, molecular biology, protein purification, Raman spectroscopy and chemometrics. She started independent consulting work right after getting her second MS degree from Stephen Byrn’s lab Read more

Improved Pharma announces new collaboration2021-08-20T13:23:16+00:00

Improved Pharma has Expanded their Laboratory Space to Support the Growing Business

WEST LAFAYETTE, IND. (PRWEB) APRIL 26, 2021 Improved Pharma is delighted to announce the expansion of its current laboratory to accommodate additional research capabilities. The addition of the newly acquired laboratory facility in the Purdue Kurz Technology Center has effectively doubled the previous laboratory space and will allow for the acquisition of new instrumentation in Read more

Improved Pharma has Expanded their Laboratory Space to Support the Growing Business2021-04-26T12:13:21+00:00

Improved Pharma announces recent publication on expediting preclinical formulation development of amorphous lapatinib using mini-tab formulations in pediatrics

Dr, Stephen Byrn, CSO of Improved Pharma, was a key contributor to a recent publication describing the usefulness of mini-tablets in monitoring the dose-response of lapatinib solid amorphous dispersions in juvenile pigs.   Juvenile pigs have been well-established as an effective pediatric model.  The use of mini-tabs allowed for dose flexibility as the the amount of tablets dosed could Read more

Improved Pharma announces recent publication on expediting preclinical formulation development of amorphous lapatinib using mini-tab formulations in pediatrics2021-04-19T12:26:44+00:00

Improved Pharma announces new publication on amorphous dispersions

A recent collaboration with our colleagues further advances the field of X-ray pair distribution function analysis applied to the analysis of amorphous solid dispersions. In this paper, we present the results of different polymer:flubendazole drug dispersions exposed to aging conditions. We discovered that if the polymer has ion-base interactions with the drug, the resulting Read more

Improved Pharma announces new publication on amorphous dispersions2021-04-12T15:10:54+00:00

Improved Pharma Announces New UV-Vis Capabilities and Expanded Dissolution Services

WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 15, 2020 Improved Pharma has expanded their offerings by acquiring S. I. Photonics’ top-of-the-line spectrophotometer, model 440. This model has a high sensitivity, low noise CCD detector that enables the collection of a full spectrum within a second. The power of this instrument is enhanced by the number of accessories and Read more

Improved Pharma Announces New UV-Vis Capabilities and Expanded Dissolution Services2020-09-16T19:51:23+00:00

Improved Pharma Announces New Collaborations Enabling Expansion Of Services

WEST LAFAYETTE, IND. (PRWEB) JULY 20, 2020 Improved Pharma is pleased to announce new collaborations with Westport Pharmaceutical Consulting, LLC (dba WPC, LLC) and Ravine Pharmaceuticals LLC enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development. These additions bring a vast amount of relevant industrial Read more

Improved Pharma Announces New Collaborations Enabling Expansion Of Services2020-07-21T14:03:08+00:00

Improved Pharma Introduces Synchrotron-Based Fast to IND (S-fIND) Development Services

Accelerated development is a complex and difficult task. S-fIND (Synchrotron-based fast to IND) is a strategy to speed development of the most difficult cases using powerful X-ray methods only available at a Synchrotron X-ray source.  S-fIND integrates powerful methods with practical pharmaceutical development approaches and excellent people in a package that accelerates development. Accelerated development services Read more

Improved Pharma Introduces Synchrotron-Based Fast to IND (S-fIND) Development Services2020-06-04T00:32:02+00:00

Improved Pharma Announces New Raman Microscopy Abilities and Collaboration with Chemical Microscopy, LLC

WEST LAFAYETTE, IND. (PRWEB) JUNE 02, 2020 In response to growing demands for services, Improved Pharma, LLC is pleased to announce a collaboration with Dr. Dale K. Purcell of Chemical Microscopy, LLC to provide services related to microscopy and microspectroscopy to Improved Pharma clients. With this collaboration comes the acquisition of HORIBA’s Xplora Series Raman Microscope. Raman mapping is a powerful Read more

Improved Pharma Announces New Raman Microscopy Abilities and Collaboration with Chemical Microscopy, LLC2020-06-02T21:38:49+00:00

Are Polymorphs Obvious?

Not according to the United States Court of Appeals, citing Improved Pharma’s CSO Steve Byrn’s early paper on polymorph screening. The United States Court of Appeals for the Federal Circuit is known as the Supreme Court of patents, and its rulings are typically considered as significant landmarks in the patent and innovation field.  In a Read more

Are Polymorphs Obvious?2020-06-01T17:24:49+00:00

Improved Pharma announces expansion of services to include infrared microspectroscopy and hot stage optical microscopy

WEST LAFAYETTE, IN (PRWEB) MAY 06, 2020 Improved Pharma has added new capabilities to their existing microscopy services. Now in addition to stereomicroscopy and polarized light microscopy, Improved Pharma can provide analysis via infrared microspectroscopy and hot stage optical microscopy. Improved Pharma has expanded their in-house microscopy services. In addition to stereomicroscopy and polarized light Read more

Improved Pharma announces expansion of services to include infrared microspectroscopy and hot stage optical microscopy2020-05-06T12:50:10+00:00
Go to Top